Prismic Pharmaceuticals
Scottsdale · Founded 2011
About Prismic Pharmaceuticals
Prismic Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing novel prescription medical foods for the clinical dietary management of the metabolic processes associated with disorders commonly seen in the aging “baby boomer” population. These include disorders of the central nervous system (CNS), as well as conditions where inflammation is an underlying or significant cause of the disorder.. The company's initial product candidates are focused on the use of a highly purified form of Omega-3 fatty acids in combination with other molecules for the treatment of CNS disorders, and are protected by a series of issued U.S. and foreign composition and use patents.
Company Facts
- Founded: 2011
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Funding stage: M&A
- Last round: Seed (Feb 2013)
- Website: http://www.prismicpharma.com
- Phone: +1 480-422-1813
Industries & Categories
Biotechnology, Developer Platform, Medical
Canonical: https://fsome.com/organization/prismic-pharmaceuticals-2283847 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.